Establishment of pandemic influenza vaccine production capacity at Bio Farma, IndonesiaSUHARDONO, Mahendra; UGIYADI, Dori; NURNAENI, Ida et al.Vaccine. Supplement. 2011, Vol 29, Num 1, issn 1359-5938, A22-A25Article

Domestic influenza vaccine production in Mexico: A state-owned and a multinational company working together for public healthPONCE-DE-LEON, Samuel; VELAZQUEZ-FERNANDEZ, Ruth; BUGARIN-GONZALEZ, Jose et al.Vaccine. Supplement. 2011, Vol 29, Num 1, issn 1359-5938, A26-A28Article

The Vaccine Formulation Laboratory: A platform for access to adjuvantsCOLLIN, Nicolas; DUBOIS, Patrice M.Vaccine. Supplement. 2011, Vol 29, Num 1, issn 1359-5938, A37-A39Article

Prevenar experienceARGUEDAS, Adriano; SOLEY, Carolina; ABDELNOUR, Arturo et al.Vaccine. Supplement. 2011, Vol 29, Num 3, issn 1359-5938, C26-C34Article

The pharmacoeconomics of pneumococcal conjugate vaccines in Latin AmericaGIGLIO, Norberto; MICONE, Paula; GENTILE, Angela et al.Vaccine. Supplement. 2011, Vol 29, Num 3, issn 1359-5938, C35-C42Article

The future of pneumococcal disease preventionRODGERS, Gail L; KLUGMAN, Keith P.Vaccine. Supplement. 2011, Vol 29, Num 3, issn 1359-5938, C43-C48Article

Participatory decision-making through the Advisory Committee on Communicable Diseases: The Sri Lankan experiencePUSHPA RANJAN WIJESINGHE; PALIHAWADANA, Paba; THELGE SUDATH ROHANA PEIRIS et al.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A96-A103Article

Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjectsSATHER, D. Noah; STAMATATOS, Leonidas.Vaccine. Supplement. 2010, Vol 28, Num 2, issn 1359-5938, B8-B12Article

Neutralizing antibodies in SIV control: Co-impact with T cellsYAMAMOTO, Hiroyuki; MATANO, Tetsuro.Vaccine. Supplement. 2010, Vol 28, Num 2, issn 1359-5938, B13-B17Article

Contribution of Cyclophilin A to determination of simian immunodeficiency virus tropism: A progress updateTAKEUCHI, Hiroaki.Vaccine. Supplement. 2010, Vol 28, Num 2, issn 1359-5938, B51-B54Article

Adjuvant Systems Educational SupplementSPIER, Ray E.Vaccine. Supplement. 2010, Vol 28, Num 3, issn 1359-5938, 44 p.Serial Issue

Seasonal Influenza Vaccines: An update for health care professionalsPOLAND, Gregory A.Vaccine. Supplement. 2010, Vol 28, Num 4, issn 1359-5938, 55 p.Serial Issue

Unmet needs in modern vaccinology Adjuvants to improve the immune responseLEROUX-ROELS, Geert.Vaccine. Supplement. 2010, Vol 28, Num 3, issn 1359-5938, C25-C36Article

The need for quadrivalent vaccine against seasonal influenzaBELSHE, Robert B.Vaccine. Supplement. 2010, Vol 28, Num 4, issn 1359-5938, D45-D53Article

Brucellosis: A Transboundary Zoonotic DiseaseOLSEN, Steven C; PLUMB, Glenn E; WILLER, Richard D et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, 87 p.Conference Proceedings

Comparative study of the immunobiological properties of live brucellosis vaccinesSALMAKOV, K. M; FOMIN, A. M; KLIMANOV, A. I et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F35-F40Conference Paper

Designing vaccines against cattle brucellosisSHUMILOV, Konstantin V; SKLYAROV, Oleg; KLIMANOV, Arkadii et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F31-F34Conference Paper

Development and characterization of a modified Komarov's bullet for ballistic delivery of live Brucella abortus strains 82 and 19 to cattle and bisonDENISOV, Alexander A; KARPOVA, Olga M; KOROBOVTSEVA, Yuliya S et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F23-F30Conference Paper

Targeted prevention of brucellosis in cattle, sheep, and goats in the Russian FederationSKLYAROV, Oleg; SHUMILOV, Konstantin; KLIMANOV, Arkadii et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F54-F58Conference Paper

Smallpox vaccines for biodefenseKENNEDY, Richard B; OVSYANNIKOVA, Inna; POLAND, Gregory A et al.Vaccine. Supplement. 2009, Vol 27, Num 4, issn 1359-5938, D73-D79Article

Rotavirus vaccines: The role of researchers in moving evidence to actionWECKER, John R; PHILLIPS, Deborah C; HAYES, Janie et al.Vaccine. Supplement. 2009, Vol 27, Num 5, issn 1359-5938, F4-F6Article

Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005―2007FLEM, Elmira T; KASYMBEKOVA, Kaliya T; VAINIO, Kirsti et al.Vaccine. Supplement. 2009, Vol 27, Num 5, issn 1359-5938, F35-F39Article

Evaluation of rotavirus vaccines in Asia—Are there lessons to be learnt?MIRZAYEVA, R; STEELE, A. D; PARASHAR, U. D et al.Vaccine. Supplement. 2009, Vol 27, Num 5, issn 1359-5938, F120-F129Article

Anti-infective antibodies—Reviving an old paradigmLACHMANN, Peter.Vaccine. Supplement. 2009, Vol 27, Num 6, issn 1359-5938, G33-G37Conference Paper

Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunityPRCHAL, Michaela; PILZ, Andreas; SIMMA, Olivia et al.Vaccine. Supplement. 2009, Vol 27, Num 6, issn 1359-5938, G17-G20Conference Paper